Screening is the First Line of Defense: Testing for Hepatitis B, Hepatitis C, & HIV

The Results are In

Podcast Episode: Screening is the First Line of Defense: Testing for Hepatitis B, Hepatitis C, & HIV

Click HERE to listen

EPISODE SUMMARY

In this episode of Results Are In by Quest Diagnostics, Jen Jenkins is joined by Dr. Meghan W. Starolis, Senior Science Director of Infectious Disease at Quest Diagnostics, to discuss the importance of universal screening for hepatitis B, hepatitis C, and HIV. 

In this episode 

• Dr. Starolis will explain the CDC’s latest recommendations, the real-world impact of co-infections, and why regular testing is critical even for patients without symptoms.
• She will break down how Quest supports clinicians with tools like the HBV Triple Screen panel, which simplifies complex interpretations, and highlights recent innovations in HIV testing, including updated algorithms and clearer reporting for providers.
• Listeners will also gain insights into what an HIV “blip” means and how Quest is addressing provider feedback to improve patient care.

This episode is essential for healthcare professionals and patients alike who want to better understand why screening is the first step in prevention, care, and improved outcomes.

Recording Date: September 12, 2025

Date posted on the CEC: September 25, 2025

Presenter:

• Jen Jenkins, Senior Marketing Manager for Clinical Solutions, Quest Diagnostics
• Dr. Meghan W. Starolis, Senior Science Director for Infectious Disease, Quest Diagnostics

Time of talk:  18.57 minutes

Disclosure: The content was current as of the time of recording in 2025